Minister Butler's media

Two breakthrough medicines will be available free of charge to Australians with extremely rare and life-threatening inherited diseases, from 1 April 2023.

Read the transcript for Minister Butler's press conference on Trikafta; and Medicare compliance

Read the transcript of Minister Butler's interview with Luke Grant on expanded PBS access to Trikafta for children aged 6-11 years; and Better Access.

Read the transcript of Minister Butler's interview with Sarah Abo and Karl Stefanovic on expanded access to Trikafta for children aged 6-11; Independent review into Medicare compliance.

From 1 May 2023, children aged 6 to 11 with cystic fibrosis will have access to the medicine Trikafta® (elexacaftor/tezacaftor/ivacaftor and ivacaftor), through the Pharmaceutical Benefits Scheme (PBS).

The Albanese Government has today released the findings of a review into the compliance system that underpins Medicare.

Read the transcript of Minister Butler's press conference in Canberra on expanded access to subsidised paxlovid; COVID-19 2023 booster dose ad campaign; COVID-19 leave grants for aged care workers; Chief Medical Officer’s fourth wave report.

From 1 April, more than 160,000 people aged 60 to 69 will have access to the antiviral treatment Paxlovid as the Albanese Government expands eligibility under the Pharmaceutical Benefits Scheme (PBS).

Read the transcript of the radio interview between Minister Butler and Chris O'Keefe on general practice, skin cancer checks, and the May Budget.

Read the transcript of Minister Butler's doorstop in Canberra on vaping.

Read the transcript of Minister Butler and Lisa Millar's television interview on vaping, and the First Nations Referendum Working Group.

Read the transcript of the radio interview with Minister Butler and Patricia Karvelas on vaping and the National Occupational Respiratory Disease Registry.

Read the transcript of Minister Butler and Raf Epstein's radio interview on vaping, and primary health.

Read the transcript of the radio interview between Minister Butler and Leon Compton on vaping.

The Albanese Government has today introduced key legislation to further drive transparency and accountability across the aged care sector.

Read the transcript of the radio interview between Minister Butler and Ben Fordham on the diabetes drug, Fiasp.

The Australian Government has secured access to Fiasp and Fiasp FlexTouch on the Pharmaceutical Benefit Scheme (PBS) for Australians living with Type 1 diabetes for the next six months.

Through the Medical Research Future Fund, nearly 200 ground-breaking medical research projects will share in more than $382 million in grants, including more than $32 million to improve First Nations health.

The Albanese Government is funding new research that could help prevent mitochondrial disease from being passed on to children by their mothers.

Australia’s pre-departure COVID-19 testing requirements for passengers arriving from the People’s Republic of China, including the Special Administrative Regions of Hong Kong and Macau, will cease applying to flights that land in Australia at 12.01am on 11 March 2023.

Australians are being encouraged to fill their prescriptions for medicines, especially as the maximum out of pocket cost for most medicines on the Pharmaceutical Benefits Scheme is now $12.50 lower.

Read the transcript of Minister Butler's doorstop on NSW Medicare Urgent Care Clinics Expressions of Interest, general practice, 'my health' app, digital health systems, TGA cough syrup recall, mental health and Distribution Priority Areas.

From 1 March 2023, Australians with recurrent melanoma will have a new treatment option subsidised by the Pharmaceutical Benefits Scheme.

An Expression of Interest for 14 Medicare Urgent Care Clinics locations across metropolitan and regional New South Wales will open on 2 March 2023.

Read the transcript of Minister Butler's and Assistant Minister Kearney's press conference on the 10 Year National Action Plan for the health and wellbeing of LGBTIQ+ people; LGBTIQ+ Health Advisory Group; research funding for the LGBTIQ+ community; WorldPride; health disparities for LGBTIQ+ people.